No abstract available
MeSH terms
-
Acute Disease
-
Animals
-
Antithrombin III / therapeutic use
-
Blood Coagulation Disorders / etiology*
-
Complement Activation
-
Cytokines / toxicity
-
Disseminated Intravascular Coagulation / drug therapy
-
Disseminated Intravascular Coagulation / etiology
-
Endotoxemia / blood
-
Endotoxemia / complications
-
Fibrin / metabolism
-
Gene Expression Regulation
-
Hemorrhage / blood
-
Hemorrhage / classification
-
Humans
-
Lipoproteins / physiology
-
Lipoproteins / therapeutic use
-
Lung Injury*
-
Primates
-
Protein C / therapeutic use
-
Reactive Oxygen Species
-
Respiratory Distress Syndrome / blood*
-
Respiratory Distress Syndrome / complications
-
Sepsis / blood*
-
Sepsis / complications
-
Thromboplastin / biosynthesis
-
Thromboplastin / genetics
-
Thromboplastin / physiology
-
Transcription, Genetic
-
Tumor Necrosis Factor-alpha / adverse effects
-
Tumor Necrosis Factor-alpha / pharmacology
-
Tumor Necrosis Factor-alpha / physiology
Substances
-
Cytokines
-
Lipoproteins
-
Protein C
-
Reactive Oxygen Species
-
Tumor Necrosis Factor-alpha
-
lipoprotein-associated coagulation inhibitor
-
Antithrombin III
-
Fibrin
-
Thromboplastin